Neelam V Desai (Neelam Desai)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Breast Cancer Risk

Sentinel Lymph Node

Top Venues

JCO precision oncology

JCO oncology practice

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Neelam V Desai, Antoinette R Tan
Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1 / 2 -Mutated Breast Cancers in the High-Risk, Early-Stage Setting. JCO precision oncology 7 (2023)
Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke M Lucassen, Nadine M Tung, Claudine Isaacs
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 7 (2023)
Neelam V Desai, Antoinette R Tan
Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1 / 2 -Mutated Breast Cancers in the High-Risk, Early-Stage Setting. JCO precision oncology 7 (2023)
Neelam V Desai, Dana Zakalik, Mark R Somerfield, Nadine M Tung
Q and A: A New Standard of Care for Germline BRCA1 and/or BRCA2 Mutation Carriers With Early-Stage Breast Cancer. JCO oncology practice 18 (6) (2022)
Adrienne G Waks, Neelam V Desai, Tianyu Li, Philip D Poorvu, Ann H Partridge, Natalie Sinclair, Laura M Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M Rosenberg, Elizabeth Frank, Sara M Tolaney, Ian E Krop, Nadine M Tung, Nabihah Tayob, Tari A King, Elizabeth A Mittendorf, Eric P Winer
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer. NPJ breast cancer 8 (1) (2022)
Nadine M Tung, Neelam V Desai
Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Neelam V Desai, Nadine M Tung
Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier. The breast journal 26 (8) (2020)
Neelam V Desai, Siddhartha Yadav, Felipe Batalini, Fergus J Couch, Nadine M Tung
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years. Cancer 127 (6) (2020)